Challenging the current model of early-onset myasthenia gravis pathogenesis in the light of the MGTX trial and histological heterogeneity of thymectomy specimens-Reference-Cited by-同舟云学术

Challenging the current model of early-onset myasthenia gravis pathogenesis in the light of the MGTX trial and histological heterogeneity of thymectomy specimens

Published:2018-01-28 Issue:1 Volume:1413 Page:82-91
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Weis Cleo-Aron¹,Schalke Berthold²,Ströbel Philipp³,Marx Alexander¹

Affiliation:

1. Institute of Pathology, University Medical Centre Mannheim; University of Heidelberg; Mannheim Germany

2. Department of Neurology, University Hospital Regensburg; University of Regensburg; Regensburg Germany

3. Institute of Pathology, University Medical Center Göttingen; University of Göttingen; Göttingen Germany

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nyas.13563/fullpdf

Reference92 articles.

1. Myasthenia gravis-autoantibody characteristics and their implications for therapy;Gilhus;Nat. Rev. Neurol.,2016

2. Myasthenia gravis: subgroup classifications-authors' reply;Gilhus;Lancet Neurol,2016

3. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms;Berrih-Aknin;J. Autoimmun.,2014

4. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes;Marx;Autoimmun. Rev.,2013

5. Late-onset myasthenia gravis-CTLA4(low) genotype association and low-for-age thymic output of naive T cells;Chuang;J. Autoimmun.,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis;Acta Neuropathologica;2024-06

2. Effect of thymectomy on the frequencies of peripheral regulatory B and T lymphocytes in patients with Myasthenia gravis-a pilot study;International Journal of Neuroscience;2023-09-09

3. The Duke Myasthenia Gravis Clinic Registry: II. Analysis of outcomes;Muscle & Nerve;2023-02-20

4. Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications;Journal of Autoimmunity;2022-10

5. Pathological Aspects of Mediastinal Tumors in Children and Adolescents;Pediatric Oncology;2022